Published by Josh White on 24th October 2022
(Sharecast News) - Women's health and cancer therapeutics company ValiRx announced the formation of a new partially-owned subsidiary, Cytolytix, on Monday, which had signed an intellectual property licence agreement with King's College London (KCL).
URL: http://www.digitallook.com/dl/news/story/33056324/...